[26] [27] Ultimately, treatment decisions should be made collaboratively, based on current evidence, regulatory approvals, and individualised assessment of benefits and risks
Major players like Novo Nordisk, Eli Lilly, and AstraZeneca are making strategic investments
Segmentation Overview Segmentation Overview Drug Exenatide Byetta Bydureon Liraglutide Victoza Lixisenatide Lyxumia Dulaglutide Trulicity Semaglutide Ozempic Geography Germany Spain Italy France United Kingdom Russia Rest of Europe Data Sources, Market Sizing, and Validation Data Sources, Market Sizing, and Validation Desk Research Desk work starts by mapping the treated patient pool and the therapy environment in Europe, before numbers are modeled
This is where the gender story gets particularly interesting
The written permission of Cambridge University Press must be obtained prior to any commercial use